Grand Rapids Oncology Program

Grand Rapids, Michigan 49503

0 studies enrolling now · 8 studies all time

What they study most

Colorectal Cancer, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme, HER2 Negative Breast Cancer, HER2 Positive Esophagogastric Cancer, Kidney Cancer, Metastatic Melanoma, Neuroendocrine Carcinoma

Studies at this site

• Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme — Completed
• A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) — Completed
• Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy — Completed
• Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer — Completed
• Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer — Stopped early
• Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers — Completed
• OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma — Completed
• Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma — Completed